Mark For: RSM™ trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88129597 |
Mark Literal Elements | RSM |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2019-08-19 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Rachelle A. Dubow, Esquire |
Attorney Docket Number | 112933-0009 |
Law Office Assigned | M10 |
Employee Name | HARDY LUDLOW, TARAH KI |
2018-09-24 | Application Filed |
2018-12-04 | Published |
2018-12-04 | Published for Opposition |
2019-08-19 | Location: INTENT TO USE SECTION |
2019-08-19 | Status: Live/Pending |
2020-01-07 | Transaction Date |
2021-01-28 | Status: A fourth request for extension of time to file a Statement of Use has been granted. |
Party: | ![]() |
Address | 200 Inner Belt Road, Suite 400 Somerville, MASSACHUSETTS UNITED STATES 02143 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives in the nature of dietary supplements for medical purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives in the nature of dietary supplements for medical purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-01-30 | |
TEAS EXTENSION RECEIVED | 2021-01-28 | |
EXTENSION 4 GRANTED | 2021-01-28 | 98765 |
EXTENSION 4 FILED | 2021-01-28 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-07-29 | |
TEAS EXTENSION RECEIVED | 2020-07-27 | |
EXTENSION 3 GRANTED | 2020-07-27 | 98765 |
EXTENSION 3 FILED | 2020-07-27 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-01-17 | |
TEAS EXTENSION RECEIVED | 2020-01-15 | |
EXTENSION 2 GRANTED | 2020-01-15 | 98765 |
EXTENSION 2 FILED | 2020-01-15 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-08-20 | |
CORRECTED NOA E-MAILED | 2019-08-20 | |
EXTENSION 1 GRANTED | 2019-08-19 | 65362 |
DIVISIONAL PROCESSING COMPLETE | 2019-08-19 | |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-08-07 | 65362 |
TEAS REQUEST TO DIVIDE RECEIVED | 2019-07-25 | |
TEAS EXTENSION RECEIVED | 2019-07-25 | |
EXTENSION 1 FILED | 2019-07-25 | 65362 |
DIVISIONAL REQUEST RECEIVED | 2019-07-25 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-01-29 | |
PUBLISHED FOR OPPOSITION | 2018-12-04 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-12-04 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-11-14 | |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2018-11-01 | 76568 |
ASSIGNED TO LIE | 2018-10-27 | 76568 |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-10-15 | 6328 |
EXAMINERS AMENDMENT E-MAILED | 2018-10-15 | 6328 |
EXAMINERS AMENDMENT -WRITTEN | 2018-10-15 | 76509 |
EXAMINER'S AMENDMENT ENTERED | 2018-10-15 | 88888 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-10-15 | |
ASSIGNED TO EXAMINER | 2018-10-10 | 76509 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-09-29 | |
NEW APPLICATION ENTERED IN TRAM | 2018-09-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.